Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Idexx Laboratories (GB:0J8P)
LSE:0J8P
Idexx Laboratories (0J8P) Share Price & Analysis
0 Followers
0J8P Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$373.77 - $583.30
Previous Close$492.17
Volume107.00
Average Volume (3M)900.00
Market Cap
$41.03B
Enterprise Value$41.82B
Total Cash (Recent Filing)$331.70M
Total Debt (Recent Filing)$1.12B
Price to Earnings (P/E)48.9
Beta1.43
Next Earnings
May 01, 2024EPS Estimate
$2.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)10.06
Shares Outstanding83,089,381
10 Day Avg. Volume108
30 Day Avg. Volume900
Standard Deviation0.08
R-Squared0.09
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)39.68
Price to Sales (P/S)48.00
Price to Cash Flow (P/CF)41.10
P/FCF Ratio39.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.66
Enterprise Value/Gross Profit15.43
Enterprise Value/Ebitda35.02
Forecast
1Y Price Target
$621.43Price Target Upside25.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Idexx Laboratories News
PremiumPre-Earnings
Is IDXX a Buy, Before Earnings?Bulls Say, Bears Say
Bulls Say
Financial PerformanceIDXX outperformed after reporting stronger 4Q CAG Dx recurring revenue and issuing future guidance which captured consensus.
Market ExpectationsAnalyst reiterates a Buy on IDXX seeing end-market improvement and a positive outlook on the launch of its InVue Dx analyzer, expected to drive robust revenue growth.
Product LaunchThe upcoming launch of the InVue Dx analyzer by IDXX is anticipated to significantly bolster revenue growth.
Bears Say
Company PerformanceIDEXX clinical visit data turned negative again in March, suggesting potential downside risk to the company's annual expectations.
Industry TrendsVet clinic visits posted another quarter of year-over-year declines, continuing a nearly two-year negative trend.
Market SentimentSoftness in pet owner visits and wellness spending could extend, potentially affecting growth below long-term trends.
---
Options Prices
Currently, No data available
---
Ownership Overview
1.53% Insiders
28.20% Mutual Funds
28.21% Other Institutional Investors
42.07% Public Companies and
Individual Investors
0J8P FAQ
What was Idexx Laboratories’s price range in the past 12 months?
Idexx Laboratories lowest share price was $373.77 and its highest was $583.30 in the past 12 months.
What is Idexx Laboratories’s market cap?
Currently, no data Available
When is Idexx Laboratories’s upcoming earnings report date?
Idexx Laboratories’s upcoming earnings report date is May 01, 2024 which is in 5 days.
How were Idexx Laboratories’s earnings last quarter?
Idexx Laboratories released its earnings results on Feb 05, 2024. The company reported $2.32 earnings per share for the quarter, beating the consensus estimate of $2.124 by $0.196.
Is Idexx Laboratories overvalued?
According to Wall Street analysts Idexx Laboratories’s price is currently Undervalued.
Does Idexx Laboratories pay dividends?
Idexx Laboratories does not currently pay dividends.
What is Idexx Laboratories’s EPS estimate?
Idexx Laboratories’s EPS estimate is $2.7.
How many shares outstanding does Idexx Laboratories have?
Idexx Laboratories has 83,089,380 shares outstanding.
What happened to Idexx Laboratories’s price movement after its last earnings report?
Idexx Laboratories reported an EPS of $2.32 in its last earnings report, beating expectations of $2.124. Following the earnings report the stock price went up 7.06%.
Which hedge fund is a major shareholder of Idexx Laboratories?
Among the largest hedge funds holding Idexx Laboratories’s share is Iron Triangle Partners LP. It holds Idexx Laboratories’s shares valued at 42M.
---
Idexx Laboratories Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$621.43 (25.86% Upside)
$621.43 (25.86% Upside)
Blogger Sentiment
Bullish
GB:0J8P Sentiment 83%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $25.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.85%
12-Months-Change
Fundamentals
Return on Equity
80.74%
Trailing 12-Months
Asset Growth
18.68%
Trailing 12-Months
Company Description
Idexx Laboratories
Maine-based IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments.
---
0J8P Company Deck
---
0J8P Earnings Call
Q4 2024
0:00 / 0:00
---
0J8P Revenue Breakdown
34.93% Reference laboratory diagnostic and consulting services
32.46% IDEXX VetLab consumables
9.41% Rapid assay products
7.63% Veterinary software, services and diagnostic imaging systems
15.58% Other
---
0J8P Stock 12 Months Forecast
Average Price Target
$621.43
▲(25.86% Upside)
Technical Analysis
Best Analysts Covering 0J8P
1 Year
1 Year Success Rate
12/16 ratings generated profit
1 Year Average Return
+22.78%
reiterated a buy rating 3 months ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +22.78% per trade.
---